Recent Updates
Recently added Catalysts
VNDA Neutral Sentiment

Vanda Pharmaceuticals to Announce Second Quarter 2024 Financial Results on July 31, 2024

Friday, July 26, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Vanda Pharmaceuticals has announced that it will release its financial results for the second quarter of 2024 on July 31, 2024, after market close. A conference call is scheduled for the same day at 4:30 PM ET to discuss these results and other corporate activities. Investors are encouraged to prepare in advance if they wish to participate in the call, which will also be accessible via Vanda's website. A replay of the call will be available for a limited time after the event.
Price reaction · baseline $6.15 (2024-07-25 close) · hit after-hours · 1 other VNDA headline(s) in the window, move may be shared
day 0 close
+0.5%

Market Sentiment Analysis

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+121%
120-day peak, hindsight
Typical move
19.9%
average across 7 past catalysts
Cash runway
~16 mo
Low dilution risk
Lead asset
Imsidolimab
Phase 2 · Palmoplantar Pustulosis

Full Press Release Details

Conference Call and Webcast to Follow
WASHINGTON, July 26, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the second quarter 2024 on Wednesday, July 31, 2024, after the market closes.
Vanda will host a conference call at 4:30 PM ET on Wednesday, July 31, 2024, during which management will discuss the second quarter 2024 financial results and other corporate activities. To participate in the conference call, please dial 1-800-715-9871 (domestic) or 1-646-307-1963 (international) and use passcode 1278669.
The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.
A replay of the call will be available on Wednesday, July 31, 2024, beginning at 8:30 PM ET and will be accessible until Wednesday, August 7, 2024, at 11:59 PM ET. The replay call-in number is 1-800-770-2030 for domestic callers and 1-609-800-9909 for international callers. The passcode number is 1278669.
About Vanda Pharmaceuticals Inc.
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies

Frequently Asked Questions

When will Vanda Pharmaceuticals release Q2 2024 results?

Vanda Pharmaceuticals will release Q2 2024 results on July 31, 2024, after market close.

How can I join Vanda's conference call?

To join the conference call, dial 1-800-715-9871 domestically or 1-646-307-1963 internationally.

When will the conference call take place?

The conference call is scheduled for 4:30 PM ET on July 31, 2024.

Where can I find a replay of the conference call?

A replay will be available starting at 8:30 PM ET on July 31, 2024, until August 7, 2024.

What is the passcode for the conference call?

The passcode for the conference call is 1278669.

ShareAdd on Google
Tags: VNDA Viatris Investor Conferences Healthcare Vanda Pharmaceuticals Q2 2024 results financial results conference call Nasdaq VNDA
Last updated: Jul 26, 2024

Biotech snapshot

Cash runway
$170M liquidity · $10M/mo burn
~16 mo
Low dilution risk
Lead asset
ImsidolimabPhase 2
Palmoplantar Pustulosis →

Catalyst track record

+121%
best trade around VNDA's most recent catalyst

Peak hindsight return over a 120-day window, across 7 tracked FDA/PDUFA catalysts for VNDA.

See every catalyst's timing & PoA →